These observations were also made in PBMCs of RA patients, presenting with an upregulation of IL-6 as well as a decreased phosphorylation of VASP in untreated RA patients as compared to RA patients treated with IL-6 receptor blockers (251). Here, IL6 is linked to rheumatoid arthritis.